| Pharmaceutical Information |
| Drug Name |
Antithrombin alfa |
| Drug ID |
BADD_D00149 |
| Description |
Antithrombin Alfa is a recombinant antithrombin , an anticoagulant, that is used for the prevention of thromboembolic events in patients that have hereditary deficiency of antithrombin in high risk situations. |
| Indications and Usage |
Antithrombin alfa is a recombinant antithrombin it is indicated for the prevention of peri-operative and peri-partum thromboembolic events in patients with hereditary deficiency of antithrombin.
|
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB11166
|
| KEGG ID |
D08858
|
| MeSH ID |
D000991
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D05JRG
|
| NDC Product Code |
Not Available |
| UNII |
AWV6I5L6H2
|
| Synonyms |
Antithrombins | Direct Antithrombin | Antithrombin, Direct | Direct Antithrombins | Antithrombins, Direct | Direct Thrombin Inhibitors | Thrombin Inhibitors, Direct | Direct Thrombin Inhibitor | Inhibitor, Direct Thrombin | Thrombin Inhibitor, Direct | Antithrombin |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
84720-88-7 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
